Roivant Sciences Ltd. (ROIV) Stock | Share Price | BMG762791017
ROIV · Health Care ·
United States
Roivant Sciences Ltd. (ROIV) is a company in the Health Care sector, based in United States. The stock is held in 17 ETFs we track – with its largest weight of 0.28 % in XUHC (msci-usa-health-care). That means you can hold Roivant Sciences indirectly and diversified through an ETF savings plan.
Above-average ETF coverage: 17 of the 95 ETFs we cover hold Roivant Sciences, spread across 8 indices. That puts the stock in more ETFs than 77.9 % of the 4,278 stocks we cover.
Price chart
Performance
| Year to date | +55.9 % | 1 year | +175.9 % |
|---|---|---|---|
| 1 month | +2.6 % | 3 months | +19.1 % |
| Calendar year 2025 | +83.4 % | ||
| Calendar year 2026 | +57.5 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Revolution Medicines Inc. | +0.47 | |
| Natera Inc. | +0.45 | |
| Russell 2000 | +0.42 | |
| FIDA | +0.42 | |
| Delta Air Lines Inc. | +0.40 | |
| Lam Research Corporation | +0.40 | |
| Tradeweb Markets Inc. Class A | -0.36 | |
| Chevron Corporation | -0.34 | |
| T-Mobile US Inc. | -0.33 |
Key financials
Latest reported fiscal year (FY2025, period end 2026-03-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 0.0 | 4.3 | 13294.2 % |
| FY2024 | 0.0 | -0.2 | -592.0 % |
| FY2025 | 0.0 | -0.3 | -3629.2 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 0.28 % |
| XUHL | msci-usa-health-care | 0.28 % |
| SPFS | msci-world-health-care | 0.21 % |
| XDWH | msci-world-health-care | 0.21 % |
| XDEM | msci-world-momentum | 0.05 % |
| XD9U | msci-usa | 0.03 % |
| XD9D | msci-usa | 0.03 % |
| EUNL | msci-world | 0.02 % |
| XDWD | msci-world | 0.02 % |
| SPPW | msci-world | 0.02 % |
| XDWL | msci-world | 0.02 % |
| WIMI | msci-world-imi | 0.02 % |
| SWWD | msci-world | 0.02 % |
| SPYY | msci-acwi | 0.01 % |
| IUSQ | msci-acwi | 0.00 % |
| SPYI | msci-acwi-imi | 0.00 % |
| SPSA | msci-acwi-imi | 0.00 % |
Want to know how much Roivant Sciences Ltd. overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Roivant Sciences — the figure counts the ETFs holding both.
Illumina Inc.ILMN · 17 shared ETFs
Revolution Medicines Inc.RVMD · 17 shared ETFs · r +0.47
Insmed IncorporatedINSM · 16 shared ETFs- Medline Inc. Class AMDLN · 16 shared ETFs
Natera Inc.NTRA · 16 shared ETFs · r +0.45- Neurocrine Biosciences Inc.NBIX · 16 shared ETFs
United Therapeutics CorporationUTHR · 17 shared ETFs- Royalty Pharma plc Class ARPRX · 17 shared ETFs
Latest Investment Intelligence News: Stocks
· Risk-onArbitrum is the day's top gainer, up 12.4% – September 2, 2026
· Risk-offFilecoin surges 14.2% – September 1, 2026
· MixedArbitrum climbs 29.8% – August 31, 2026
· Risk-offCrypto, commodities & FX this week: Arbitrum +41.3% · August 24–28, 2026
· Risk-offThe week in markets: DAX lags the week (-2.2%) · August 24–28, 2026